Stem Cell Manufacturing Market, By Type (Product and Services), By Application (Stem Cell Therapy, Drug Discovery and Development, and Stem Cell Banking), By End-User (Pharmaceutical and Biotechnology Companies & CRO, Cell Banks and Tissue Banks, and Othe

Stem Cell Manufacturing Market, By Type (Product and Services), By Application (Stem Cell Therapy, Drug Discovery and Development, and Stem Cell Banking), By End-User (Pharmaceutical and Biotechnology Companies & CRO, Cell Banks and Tissue Banks, and Others), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Stem cells can be used to develop new stem cell therapies for many untreatable diseases. Stem cell therapy, also known as regenerative medicine, uses stem cells to repair diseased, dysfunctional, or injured tissues. Stem cell therapies can be used to treat neurological, autoimmune, inflammatory, and orthopedic conditions as well as traumatic injuries. Today, doctors routinely use stem cells to treat aforementioned disorders. Stem cells hold great promise for new medical treatments.

Market Dynamics:

Rise in burden of chronic/neurological diseases, increase in focus on the development of stem cell therapies, growing public awareness about therapeutic potential of stem cell, growing awareness regarding the benefits of stem cell preservation, favorable government initiatives and support are major factors expected to aid in the growth of the global stem cell manufacturing market.

For instance, in September 2021, STEMCELL Technologies, in partnership with WiCell, launched human pluripotent stem cell characterization and banking services, making it easier for pluripotent stem cell researchers to achieve critical yet often overlooked steps. Moreover, in September 2021, LifeCell International received an investment of INR 225 crore from OrbiMed Asia Partners IV in return for a minority stake, which will enable the company to make a foray into new categories, such as fertility health and cell-based therapeutics.

Key features of the study:

• This report provides in-depth analysis of the global stem cell manufacturing market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global stem cell manufacturing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include TAKARA BIO Inc., PHARMICELL Co., MEDIPOST Co., Holostem Terapie Avanzate S.r.l, Bio-Rad Laboratories, Anterogen Co., Ltd., Osiris Therapeutics, Inc (Smith & Nephew PLC), Minaris Regenerative Medicine (Hitachi Chemical), Nikon CeLL Innovation Co. Ltd. (Nikon Corporation), Medinet Co. Ltd., Cell and Gene Therapy Catapult, Bio Elpida, Miltenyi Biotec, Pluristem Therapeutics Inc., Thermo Fischer Scientific, Merck Group, Corning Incorporated, Stem Cell Technologies, Lonza Group, Becton, Dickinson and Company, Sartorius, and Cellular Dynamics (Fujifilm Holdings Corporation, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global stem cell manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cell manufacturing market.

• Global Stem Cell Manufacturing Market, By Type:
• Product
• Services
• Global Stem Cell Manufacturing Market, By Application:
• Stem Cell Therapy
• Drug Discovery and Development
• Stem Cell Banking
• Global Stem Cell Manufacturing Market, By End-User:
• Pharmaceutical and Biotechnology Companies & CRO
• Cell Banks and Tissue Banks
• Others
• Global Stem Cell Manufacturing Market, By Geography:
• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• South America
• Company Profiles:
• TAKARA BIO Inc.
• PHARMICELL Co., Ltd.
• MEDIPOST Co.
• Holostem Terapie Avanzate S.r.l.
• Bio-Rad Laboratories
• Anterogen Co., Ltd.
• Osiris Therapeutics, Inc. (Smith & Nephew PLC)
• Minaris Regenerative Medicine (Hitachi Chemical Co., Ltd.)
• Nikon CeLL Innovation Co. Ltd. (Nikon Corporation)
• Medinet Co. Ltd.
• Cell and Gene Therapy Catapult
• Bio Elpida
• Miltenyi Biotec
• Pluristem Therapeutics Inc.
• Thermo Fischer Scientific
• Merck Group
• Corning Incorporated
• Stem Cell Technologies
• Lonza Group
• Becton, Dickinson and Company
• Sartorius
• Cellular Dynamics (Fujifilm Holdings Corporation)